Gastrointestinal Therapeutics Market Size, Share, Price, Demand, Industry Analysis and Forecast 2021-2026

According to the latest report by IMARC Group, titled “Gastrointestinal Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global gastrointestinal therapeutics market size. Gastrointestinal, or GI, disorder refers to medical conditions related to the digestive system. These diseases affect the rectum, colon, small and large intestines, gall bladder, liver, and stomach. GI disorders are characterized by various symptoms, such as bloating, pain, nausea, diarrhea, heartburn, and constipation. Gastrointestinal drugs are prescribed based on endoscopy, blood tests, and imaging tests. There are various GI therapeutics available targeted at providing relief and minimizing gastric acidity. Some of the common therapeutics include prescription and over-the-counter (OTC) drugs, such as Afinitor, Dificid, antacids, laxatives, and Aciphex.

Request Free Sample Report: https://www.imarcgroup.com/gastrointestinal-therapeutics-market/requestsample

The global GI therapeutics market is primarily being driven by the increasing prevalence of GI diseases, such as ulcerative colitis, peptic ulcer diseases, and irritable bowel syndrome. In addition to this, the rising geriatric population, which is more prone to GI ailments, is further supporting the market growth. Moreover, the development of cellular therapies and innovative biosimilars for the treatment of GI disorders is also contributing to the growth of the market. Rising health consciousness amongst consumers, improvements in healthcare infrastructure, and innovations in research and development (R&D) activities are some of the factors driving the GI therapeutics market further toward growth. Looking forward, IMARC Group expects the global gastrointestinal therapeutics market to exhibit moderate growth during 2021-2026.

Breakup by Type:

• Branded
• Generic

Breakup by Route of Administration:

• Oral
• Intravenous
• Others

Breakup by Application:

• Ulcerative Colitis
• Crohn's Disease
• GERD
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Competitive Landscape with Key Player:

• Abbott Laboratories
• AbbVie Inc.
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Bayer Aktiengesellschaft
• GlaxoSmithKline Plc
• Janssen Biotech Inc. (Johnson & Johnson)
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi S.A.
• Takeda Pharmaceuticals

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/gastrointestinal-therapeutics-market